Objective informational resource
for industry professionals

Вас может заинтересовать:

Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
WEB only
Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…
Brand new state-of-the-art Nemera manufacturing facility inaugurated in Poland
WEB only
Brand new state-of-the-art Nemera manufacturing facility inaugurated in Poland
Based in Szczecin, this facility will significantly boost Nemera’s manufacturing capabilities and bring more drug delivery device solutions to patients. The dawn of January 25, 2023 marks a very special…
X

error

Подобається наш журнал! Розкажи про нас

RSS
Follow by Email
Facebook
Twitter
LinkedIn
LinkedIn
Share
Для копіювання будь-ласка увійдіть в свій аккаунт